APA

Rossi G. C. M., Tinelli C., Pasinetti G. M., Fusetti M., Pallavicini C., Stringa M., Vacchi S., Stringa F. & Bianchi P. E. (20110627). Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study. : Expert opinion on pharmacotherapy.

Chicago

Rossi Gemma Caterina Maria, Tinelli Carmine, Pasinetti Gian Maria, Fusetti Marina, Pallavicini Claudio, Stringa Massimo, Vacchi Sauro, Stringa Francesco and Bianchi Paolo Emilio. 20110627. Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study. : Expert opinion on pharmacotherapy.

Harvard

Rossi G. C. M., Tinelli C., Pasinetti G. M., Fusetti M., Pallavicini C., Stringa M., Vacchi S., Stringa F. and Bianchi P. E. (20110627). Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study. : Expert opinion on pharmacotherapy.

MLA

Rossi Gemma Caterina Maria, Tinelli Carmine, Pasinetti Gian Maria, Fusetti Marina, Pallavicini Claudio, Stringa Massimo, Vacchi Sauro, Stringa Francesco and Bianchi Paolo Emilio. Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study. : Expert opinion on pharmacotherapy. 20110627.